Cargando…

Additional oncological benefit of photodynamic diagnosis with blue light cystoscopy in transurethral resection for primary non‐muscle‐invasive bladder cancer: A comparative study from experienced institutes

OBJECTIVES: The objective of this work is to evaluate the additional oncological benefit of photodynamic diagnosis (PDD) using blue‐light cystoscopy in transurethral resection (TURBT) for primary non‐muscle‐invasive bladder cancer (NMIBC) based on the International Bladder Cancer Group (IBCG)‐define...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyake, Makito, Nishimura, Nobutaka, Nakahama, Tomonori, Nishimoto, Koshiro, Oyama, Masafumi, Matsushita, Yuto, Miyake, Hideaki, Fukuhara, Hideo, Inoue, Keiji, Kobayashi, Keita, Matsumoto, Hiroaki, Matsuyama, Hideyasu, Fujii, Tomomi, Hirao, Yoshihiko, Fujimoto, Kiyohide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071077/ https://www.ncbi.nlm.nih.gov/pubmed/37025476 http://dx.doi.org/10.1002/bco2.215

Ejemplares similares

Bladder cancer prospective cohort study on high‐risk non‐muscle invasive bladder cancer after photodynamic diagnosis‐assisted transurethral resection of the bladder tumor (BRIGHT study)
por: Kobayashi, Keita, et al.
Publicado: (2022)

Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method
por: Miyake, Makito, et al.
Publicado: (2021)

Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study)
por: Miyake, Makito, et al.
Publicado: (2021)

Active surveillance for nonmuscle invasive bladder cancer
por: Miyake, Makito, et al.
Publicado: (2016)

Identification of risk factors associated with oral 5-aminolevulinic acid-induced hypotension in photodynamic diagnosis for non-muscle invasive bladder cancer: a multicenter retrospective study
por: Fukuhara, Hideo, et al.
Publicado: (2021)

Photodynamic diagnosis of shed prostate cancer cells in voided urine treated with 5-aminolevulinic acid
por: Nakai, Yasushi, et al.
Publicado: (2014)

Diagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancer
por: Miyake, Makito, et al.
Publicado: (2014)

Pain reduction methods during transurethral cystoscopy
por: Łaszkiewicz, Jan, et al.
Publicado: (2021)

Is Endoscopic Transurethral Incision Really Effective for Boys with Refractory Daytime Incontinence?
por: Morizawa, Yosuke, et al.
Publicado: (2020)

Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma
por: Miyake, Makito, et al.
Publicado: (2019)

Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model
por: Inoue, Takeshi, et al.
Publicado: (2013)

Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy
por: Miyake, Makito, et al.
Publicado: (2022)

Remnant renal volume can predict prognosis of remnant renal function in kidney transplantation donors: a prospective observational study
por: Hori, Shunta, et al.
Publicado: (2021)

Pretreatment assessment and perioperative nutritional interventions for patients with bladder cancer undergoing radical cystectomy
por: Miyake, Makito, et al.
Publicado: (2018)

A prospective, single-arm trial of fluorescent ureteroscopy-assisted thulium-holmium:YAG dual laser ablation for upper urinary tract cancer: Study protocol of the FLUAM trial
por: Miyake, Makito, et al.
Publicado: (2022)

Risk stratification by means of biological age-related factors better predicts cancer-specific survival than chronological age in patients with upper tract urothelial carcinoma: a multi-institutional database study
por: Inamoto, Teruo, et al.
Publicado: (2018)

Efficacy of pembrolizumab rechallenge for metastatic urothelial carcinoma
por: Nishimura, Nobutaka, et al.
Publicado: (2022)

Transurethral cystoscopy in dogs with recurrent urinary tract infections: Retrospective study (2011‐2018)
por: Llido, Marie, et al.
Publicado: (2020)

A case in which bladder cancer invaded the ureteral orifice and was resected via photodynamic diagnosis‐assisted transurethral resection involving orally administered 5‐aminolevulinic acid
por: Watanabe, Keitaro, et al.
Publicado: (2019)

Clinical significance of subepithelial growth patterns in non-muscle invasive bladder cancer
por: Miyake, Makito, et al.
Publicado: (2011)

Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy
por: Tomioka, Atsushi, et al.
Publicado: (2015)

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
por: Tomioka, Atsushi, et al.
Publicado: (2014)

The optimal number of initial prostate biopsy cores in daily practice: a prospective study using the Nara Urological Research and Treatment Group nomogram
por: Tanaka, Nobumichi, et al.
Publicado: (2015)

Colony-stimulating factors detected in tumor cells and voided urine are potential prognostic markers for patients with muscle-invasive bladder cancer undergoing radical cystectomy
por: Morizawa, Yosuke, et al.
Publicado: (2018)

Overexpression of MicroRNA-138 Affects the Proliferation and Invasion of Urothelial Carcinoma Cells by Suppressing SOX9 Expression
por: Nitta, Yuji, et al.
Publicado: (2023)

Optimal timing of ureteroscopic lithotripsy after the initial drainage treatment and risk factors for postoperative febrile urinary tract infection in patients with obstructive pyelonephritis: a retrospective study
por: Itami, Yoshitaka, et al.
Publicado: (2021)

Review by urological pathologists improves the accuracy of Gleason grading by general pathologists
por: Nakai, Yasushi, et al.
Publicado: (2015)

Prostate diseases and microbiome in the prostate, gut, and urine
por: Miyake, Makito, et al.
Publicado: (2022)

Combined percutaneous and transurethral cystoscopy for large urethral foreign bodies: A case report and literature review
por: Albakr, Ahmed, et al.
Publicado: (2021)

Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumors
por: Ali, Nairveen, et al.
Publicado: (2021)

Arterial reconstruction using the donor’s gonadal vein in living renal transplantation with multiple renal arteries: a case report and a literature review
por: Tomizawa, Mitsuru, et al.
Publicado: (2020)

Cystoscopy
por: Back, Ivor
Publicado: (1911)

Cystoscopy
Publicado: (1928)

A Potential Application of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Combined with Photodynamic Diagnosis for the Detection of Bladder Carcinoma in Situ: Toward the Future ‘MRI-PDD Fusion TURBT’
por: Miyake, Makito, et al.
Publicado: (2019)

Comparison of cancer detection rates by transrectal prostate biopsy for prostate cancer using two different nomograms based on patient’s age and prostate volume
por: Hori, Shunta, et al.
Publicado: (2019)

Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells
por: Tatsumi, Yoshihiro, et al.
Publicado: (2020)

Trends in risk classification and primary therapy of Japanese patients with prostate cancer in Nara urological research and treatment group (NURTG) – comparison between 2004–2006, 2007–2009, and 2010–2012
por: Tanaka, Nobumichi, et al.
Publicado: (2017)

Clinical Impact of Tumor-Infiltrating Lymphocytes and PD-L1-Positive Cells as Prognostic and Predictive Biomarkers in Urological Malignancies and Retroperitoneal Sarcoma
por: Miyake, Makito, et al.
Publicado: (2020)

Response of Patients with Taxane-Refractory Advanced Urothelial Cancer to Enfortumab Vedotin, a Microtubule-Disrupting Agent
por: Miyake, Makito, et al.
Publicado: (2023)

Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma
por: Miyake, Makito, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oqr14s87f8bpfc9n47immhrf2j